<?xml version="1.0" encoding="UTF-8"?>
<p>Once the first case was identified, the infection was possibly spread from animal to human as a zoonotic agent. A second human-to-human route of transfer confirmed a surge in cases in Wuhan and globally after the shutdown of the Wuhan market and relocation of cases in China. At the time of writing this review, Although China declared that it is free of new cases, but have been reported at the beginning of April of 2020 of viral re-emergence. A surge in the reported cases in Europe (Italy, France, Spain and UK) and the USA had been reported [
 <xref rid="B15" ref-type="bibr">15</xref>]. This review is intended to provide an informed opinion on the epidemic and forms in which this initial outbreak may be handled and avoided with expert insight into the current and potential available therapies. Scientists at the Scripps Research Institute have found no proof that SARS-CoV-2 is a product of bio-engineering (manipulation) in laboratory facilities by conducting a comparative analysis of genomic data [
 <xref rid="B16" ref-type="bibr">16</xref>]. Therefore, this virus is possibly novel and subsequent natural results of the mutations that the CoVs family is renowned for having.
</p>
